Olio Labs Analysis: $5M Raised
What is Olio Labs?
Olio Labs develops AI-driven combination therapeutics targeting protein interactions for more effective treatments with fewer side effects.
Product Features & Capabilities
- Combination therapeutics, AI-driven development, targeting complex protein interactions, designed for effectiveness, reduced side effects.
How much Olio Labs raised
Pre-Seed - $4.5 Million
August 1, 2023Lead Investor: ZAKA VC, Y Combinator, Unpopular Ventures, Pioneer Fund
Who are the founders of Olio Labs
DT
David Tingley
Founder
TR
Tom Roseberry
Founder
Market Focus
Olio Labs primarily focuses on the biotechnology industry, specifically in the development of combination therapeutics using artificial intelligence to target protein interactions for more effective medical treatments.
Investors
- Pioneer Fund
- SciFounders
- Scrum Ventures
- Y Combinator
- ZAKA VC
- Unpopular Ventures
Competitors Overview
Olio Labs operates in the biotechnology sector, focusing on developing advanced combination therapeutics using artificial intelligence. Its main competitors include:
- Owkin: This AI biotech company integrates human and artificial intelligence to identify new treatments and accelerate clinical
Business Model
Utilizes AI for drug development; revenue from partnerships and licensing agreements.
See something that needs updating? Suggest edits to this profile.